Patrick J. Harrison

In recent years, Patrick has advised:

• TowerBrook Capital Partners on multiple deals, including:
  •  its 2020 sale of metals recycler, Metallo, to rival Aurubis, a deal that was subject to a Phase II review by the European Commission but cleared unconditionally following arguments made at the Oral Hearing. The deal is one of only two cases in recent years that have proceeded to a formal Statement of Objections from the Commission but resulted in an unconditional approval;
  • its sale of and re-investment in Independent Clinical Services Group; and
  • its acquisition of UK-based restaurant chain, the Azzurri Group.
• Mastercard on the first investigation by the UK’s Payment Systems Regulator under the Competition Act 1998.
• A financial services provider in relation to the first investigation by the UK’s Financial Conduct Authority under the Competition Act 1998.
• Recall Corporation in its acquisition by rival document management provider Iron Mountain, Inc. for US$2.6 billion. The deal was subject to a detailed Phase II investigation by the CMA, at the expiry of which it was approved subject to divestments which were limited to Northern Scotland.
• eBay, Inc. on its 2019 acquisition from Cox Automotive of Motors.co.uk, a UK-based vehicle advertising rival to eBay’s own eBay Motors and Gumtree Motors offerings. The UK’s CMA cleared the deal unconditionally at Phase I, notwithstanding that the CMA had initially raised concerns, and called the parties in for an Issues Meeting.
• Blackbaud, Inc. on the 2017 acquisition of its rival, JustGiving, the UK’s leading online charity donations platform. The CMA cleared the Blackbaud/JustGiving transaction unconditionally at Phase I, notwithstanding that the CMA had found the parties had a combined share of 70–80 percent in the UK online fundraising platforms sector.
• Mastercard Europe in relation to UK and EU judicial review proceedings regarding competition law-influenced aspects of the EU’s Interchange Fee Regulation and second Payment Services Directive.
• Japanese industrial manufacturer, Nidec Corporation, on the antitrust aspects of its US$1.1 billion acquisition of Embraco, a Brazil-based compressor manufacturer, a deal that was subject to parallel Phase II investigations in the EU, China, Mexico, Russia and Ukraine.
• KKR on multiple deals, including:
  • its majority acquisition of Biosynth Carbosynth, a Swiss life sciences reagents and custom synthesis and manufacturing services company;
  • its investment in Nordic Bioscience, a Danish biomarker development company; and
  • its participation in a US$530 million funding round in Wolt, a leading European food delivery business based in Finland.
• Great Hill Partners in connection with its acquisition of Notonthehighstreet, a UK online marketplace.
• Arvelle Therapeutics, a Swiss-based biopharmaceutical company, on its sale to Angelini Pharma for a total cash consideration of up to US$960 million.

• Law Society of England and Wales European Group